Business Standard

Samrat Pharmachem standalone net profit rises 38.89% in the March 2017 quarter

Image

Capital Market

Sales decline 34.70% to Rs 13.04 crore

Net profit of Samrat Pharmachem rose 38.89% to Rs 0.25 crore in the quarter ended March 2017 as against Rs 0.18 crore during the previous quarter ended March 2016. Sales declined 34.70% to Rs 13.04 crore in the quarter ended March 2017 as against Rs 19.97 crore during the previous quarter ended March 2016.

For the full year,net profit rose 423.33% to Rs 1.57 crore in the year ended March 2017 as against Rs 0.30 crore during the previous year ended March 2016. Sales rose 14.89% to Rs 71.07 crore in the year ended March 2017 as against Rs 61.86 crore during the previous year ended March 2016.

 
ParticularsQuarter EndedYear EndedMar. 2017Mar. 2016% Var.Mar. 2017Mar. 2016% Var.Sales13.0419.97 -35 71.0761.86 15 OPM %8.052.05 -5.352.05 - PBDT0.960.33 191 3.190.89 258 PBT0.610.22 177 2.500.45 456 NP0.250.18 39 1.570.30 423

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Jun 02 2017 | 5:59 PM IST

Explore News